Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Dubbs777on Aug 28, 2018 10:46am
299 Views
Post# 28529092

Emerald Health Therapeutics to Present at the Rodman & Rensh

Emerald Health Therapeutics to Present at the Rodman & Rensh
VICTORIA, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (Emerald) today announced that Chris Wagner, Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 20th Annual Global Investment Conference taking place at the St. Regis Hotel in New York, NY. Presentation details are as follows: Date: Thursday, September 6, 2018 Time: 4:15 PM Eastern Time Location: Fontainebleau Foyer (2nd floor); St. Regis New York Hotel in New York City To view the live webcast, please access the following link at the time of the presentation https://www.wsw.com/webcast/rrshq28/emhtf. An archived version of the webcast will be available for 90 days in the investor section of the Emerald Health Therapeutics website.
<< Previous
Bullboard Posts
Next >>